238 related articles for article (PubMed ID: 34923085)
1. Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker.
Harris PS; Michel CR; Yun Y; McGinnis CD; Assiri MA; Ahmadi AR; Sun Z; Roede JR; Burchill MA; Orlicky DJ; McCullough RL; Fritz KS
Alcohol; 2022 Mar; 99():35-48. PubMed ID: 34923085
[TBL] [Abstract][Full Text] [Related]
2. Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis.
Katayama A; Nakatsuka A; Eguchi J; Murakami K; Teshigawara S; Kanzaki M; Nunoue T; Hida K; Wada N; Yasunaka T; Ikeda F; Takaki A; Yamamoto K; Kiyonari H; Makino H; Wada J
Sci Rep; 2015 Nov; 5():16920. PubMed ID: 26581806
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Protein and Phosphoprotein Signatures of Alcohol-Associated Cirrhosis and Hepatitis.
Hardesty J; Day L; Warner J; Warner D; Gritsenko M; Asghar A; Stolz A; Morgan T; McClain C; Jacobs J; Kirpich I
Am J Pathol; 2022 Jul; 192(7):1066-1082. PubMed ID: 35490715
[TBL] [Abstract][Full Text] [Related]
4. Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated Hepatitis.
Argemi J; Kedia K; Gritsenko MA; Clemente-Sanchez A; Asghar A; Herranz JM; Liu ZX; Atkinson SR; Smith RD; Norden-Krichmar TM; Day LZ; Stolz A; Tayek JA; Bataller R; Morgan TR; Jacobs JM;
Am J Pathol; 2022 Dec; 192(12):1658-1669. PubMed ID: 36243044
[TBL] [Abstract][Full Text] [Related]
5. Alcoholic liver disease: A current molecular and clinical perspective.
Ohashi K; Pimienta M; Seki E
Liver Res; 2018 Dec; 2(4):161-172. PubMed ID: 31214376
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.
Kumagai K; Tabu K; Sasaki F; Takami Y; Morinaga Y; Mawatari S; Hashimoto S; Tanoue S; Kanmura S; Tamai T; Moriuchi A; Uto H; Tsubouchi H; Ido A
PLoS One; 2015; 10(11):e0143413. PubMed ID: 26599547
[TBL] [Abstract][Full Text] [Related]
7. Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.
Gala KS; Vatsalya V
Cells; 2020 Feb; 9(3):. PubMed ID: 32106390
[TBL] [Abstract][Full Text] [Related]
8. Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann-Pick Disease Type C Model Mice.
Fukaura M; Ishitsuka Y; Shirakawa S; Ushihama N; Yamada Y; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kurauchi Y; Seki T; Katsuki H; Higaki K; Matsuo M; Irie T
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466390
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease.
Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Han SH; Yang YJ; Baik GH; Bang CS; Kim DJ; Suk KT
Hepatol Int; 2024 Apr; 18(2):486-499. PubMed ID: 37000389
[TBL] [Abstract][Full Text] [Related]
10. Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis.
Furuya S; Cichocki JA; Konganti K; Dreval K; Uehara T; Katou Y; Fukushima H; Kono H; Pogribny IP; Argemi J; Bataller R; Rusyn I
Toxicol Sci; 2019 Aug; 170(2):427-437. PubMed ID: 30517762
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout mice.
Fritz KS; Galligan JJ; Hirschey MD; Verdin E; Petersen DR
J Proteome Res; 2012 Mar; 11(3):1633-43. PubMed ID: 22309199
[TBL] [Abstract][Full Text] [Related]
12. Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation.
Blaya D; Coll M; Rodrigo-Torres D; Vila-Casadesús M; Altamirano J; Llopis M; Graupera I; Perea L; Aguilar-Bravo B; Díaz A; Banales JM; Clària J; Lozano JJ; Bataller R; Caballería J; Ginès P; Sancho-Bru P
Gut; 2016 Sep; 65(9):1535-45. PubMed ID: 27196584
[TBL] [Abstract][Full Text] [Related]
13. Steroid responsiveness in alcohol-associated hepatitis is linked to glucocorticoid metabolism, mitochondrial repair, and heat shock proteins.
Hardesty J; Hawthorne M; Day L; Warner J; Warner D; Gritsenko M; Asghar A; Stolz A; Morgan T; McClain C; Jacobs J; Kirpich IA
Hepatol Commun; 2024 Mar; 8(3):. PubMed ID: 38437061
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiome and Alcohol-associated Liver Disease.
Philips CA; Schnabl B; Bajaj JS
J Clin Exp Hepatol; 2022; 12(5):1349-1359. PubMed ID: 36157139
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis.
Blaya D; Rubio-Tomás T; Rodrigo-Torres D; Lozano J; Coll M; Argemi J; Altamirano J; Affò S; Morales-Ibanez O; Gratacós-Ginès J; Pose E; Tanguy M; Issoufaly T; Rautou PE; Bataller R; Caballería J; Sancho-Bru P
Hepatol Int; 2021 Aug; 15(4):1006-1017. PubMed ID: 33954832
[TBL] [Abstract][Full Text] [Related]
16. Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Liu H; Yerevanian A; Westerhoff M; Hastings MH; Guerra JRB; Zhao M; Svensson KJ; Cai B; Soukas AA; Rosenzweig A
Diabetes; 2024 Feb; 73(2):260-279. PubMed ID: 37934943
[TBL] [Abstract][Full Text] [Related]
17. Alcohol-associated liver disease: Epidemiology and management.
Hernández-Évole H; Jiménez-Esquivel N; Pose E; Bataller R
Ann Hepatol; 2024; 29(1):101162. PubMed ID: 37832648
[TBL] [Abstract][Full Text] [Related]
18. Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis.
Taiwo M; Huang E; Pathak V; Bellar A; Welch N; Dasarathy J; Streem D; McClain CJ; Mitchell MC; Barton BA; Szabo G; Dasarathy S; ; Schaefer EA; Luther J; Day LZ; Ouyang X; Suyavaran A; Mehal WZ; Jacobs JM; Goodman RP; Rotroff DM; Nagy LE
JCI Insight; 2024 Apr; 9(9):. PubMed ID: 38573776
[TBL] [Abstract][Full Text] [Related]
19. Current Status of Alcoholic Liver Disease in Japan and Therapeutic Strategy.
Horie Y; Ebinuma H; Kikuchi M; Lamao Takanori
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2016 Aug; 51(2):71-90. PubMed ID: 30462383
[TBL] [Abstract][Full Text] [Related]
20. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
Way GW; Jackson KG; Muscu SR; Zhou H
Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
